Journal
REDOX BIOLOGY
Volume 47, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.redox.2021.102145
Keywords
Prognostic factors; Micronutrient; Mortality; Biomarkers; Prospective study
Categories
Funding
- Deutsche For-schungsgemeinschaft (DFG) [Scho 849/6-2]
- Mrs. Berta Kamprad Foundation
- BIH, Berlin Institute of Health, Berlin, Germany
Ask authors/readers for more resources
Selenium is essential for the synthesis of redox active proteins and its serum status biomarkers SELENOP and GPx3 are associated with overall survival and recurrence in patients with primary invasive breast cancer. An analysis of 1996 patients showed an inverse correlation between these biomarkers and mortality, with the highest quintile associated with significantly lower hazard ratios. Triple deficiency in selenium status biomarkers was linked to the highest mortality risk, and predicting mortality based on these biomarkers outperformed traditional tumour characteristics.
The trace element selenium is of essential importance for the synthesis of a set of redox active proteins. We investigated three complementary serum selenium status biomarkers in relation to overall survival and recurrence following diagnosis of primary invasive breast cancer in a large prospective cohort study. The Sweden Cancerome Analysis Network - Breast Initiative (SCAN-B) is a prospective population-based study including multiple participating hospitals. Main analyses included 1996 patients with a new diagnosis of primary invasive breast cancer, with blood sampling at the time of diagnosis. In sera of the patients, total serum selenium, selenoprotein P (SELENOP), and glutathione peroxidase 3 (GPx3) activity was analysed. All three biomarkers showed a positive correlation (p < 0.001), supporting the high quality of samples and analytical techniques. During a total of 13,306 person years of follow-up, 310 deaths and 167 recurrent breast cancer events occurred. In fully adjusted Cox models, all three biomarkers correlated inversely with mortality (p trend <0.001) and compared with the lowest quintile, hazard ratios (95% confidence interval) for overall survival in the highest quintile of selenium, SELENOP and GPx3 were 0.42 (0.28-0.63), 0.51 (0.36-0.73) and 0.52 (0.36-0.75), respectively. Low GPx3 activity was associated with more recurrences (Q5 vs Q1: fully adjusted HR (95%CI); 0.57 (0.35-0.92), (p(trend) = 0.005). Patients with low selenium status according to all three biomarkers (triple deficient) had the highest mortality risk with an overall survival probability of similar to 50% after 8 years, in particular as compared to those having at least one marker in the highest quintile; fully adjusted HR (95%CI); 0.30 (0.21-0.43). Prediction of mortality based on all three biomarkers outperformed established tumour characteristics like histologic grade, number of involved lymph nodes or tumour size. An assessment of Se status at breast cancer diagnosis identifies patients at exceptionally high risk for a poor prognosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available